SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

H.C. Wainwright Reiterates Neutral on Sunesis Pharmaceuticals, Lowers Price Target to $0.5

H.C. Wainwright reiterates Sunesis Pharmaceuticals (NASDAQ:SNSS) with a Neutral and lowers the price target from $1 to $0.5.

Benzinga · 05/08/2020 14:49

H.C. Wainwright reiterates Sunesis Pharmaceuticals (NASDAQ:SNSS) with a Neutral and lowers the price target from $1 to $0.5.